- Names in the news.
FEI Members: You are invited to contribute news about career moves and changes. Email Managing Editor Ellen M. Heffes, eheffes@fei.org. * Robert J. Bahash, CPA (New York City Chapter), was appointed to serve on the Board of Directors of WMS Industries Inc., in Waukegan, Ill. Bahash is Executive Vice ......
- Biotech Comes of Age
Almost 30 years after its inception, and following a long series of boom-and-bust investment cycles, the biotech industry has reached a new level of maturity. A strong performance in 2004 combined with the release of revolutionary therapies such as treatments for HIV, bone-marrow disease, chronic kidney disease and various forms ......
- Other News in Brief: Hudson Valley Resort Sells for $18.5M; Grosvenor Acquires San Jose Shopping Center; Law Firm Renews its 115,390SF Cleveland Lease; Sperry Van Ness Negotiates Three Midwestern Sales;...
Minnewaska Co. L.L.C. sold Hudson Valley Resort (pictured), a 344-room resort hotel in Kerhonkson, N.Y, to Delaware-based Everyday Logistics for $18.5 million.
- PERSONS.
The board: At Journal Communications Inc. of Milwaukee, Wis., Jonathan Newcomb and Jeanette Tully have been named to the board of directors. The former chairman and chief executive of the book publisher Simon & Schuster, Newcomb most recently has been a principal in a New York City private equity firm....
- SAN FRANCISCO EXAMINER HAS NO BUYERS SO FAR
Two big newspaper company heads say they have no interest in buying the San Francisco Examiner, reinforcing what staffers and readers have long expected: that the city, once home to five daily papers, will soon join the growing ranks of one-newspaper towns.
- International Oil & Gas Holdings Corporation Announces Appointments of New Board Members.
DALLAS -- International Oil & Gas Holdings Corporation (PINK SHEETS: IOGH), today announced that Wes Marr and John Richard Graves, have been appointed to the Company's Board of Directors. With Mr. Marr's and Mr. Graves' appointments, International Oil & Gas Holdings' Board of Directors has been expanded to five members....
- Biotechs Can Still Raise Cash in the ImClone Era
The ImClone implosion has raised doubts about their research claims, and a shaky stock market is holding down the value of their stocks, but there still are plenty of ways biotechs can find the cash they'll need to survive. They'll have to do it, though, in an environment in which ......